KDM4C and cancer: In this respect, silencing KDM4C expression by siRNA led to abnormal mitotic cells [50], as well as inhibition of cancer cell growth [25, 51] and cell death in KYSE150 and U2OS cells [39], rendering these enzymes an attractive druggable target both for research as well as for anti-cancer therapeutics.